Healthpeak Properties, Inc.

DOC · NYSE · USD

Financials

Annual
StatisticsIncome statementBalance sheetCash flowDividendsSegments

Valuation and market statistics · USD millions unless noted · ratios on the twelve months ending at each period

Line itemFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013FY2012FY2011FY2010
Valuation
Market cap$11,175$14,178$3,174$3,303$4,148$3,921$4,172$3,531$3,963$13,885$17,697$20,184$16,526$19,285$16,508–
Enterprise value$21,791$23,735$10,665$10,465$10,908$10,911$10,829$5,578$5,679$15,175$18,243$20,480$16,476$19,325$16,760–
P/E (TTM) at period end158.48×58.49×10.43×6.64×8.26×9.54×94.85×3.34×9.60×22.16×–21.94×17.05×23.74×32.03×–
P/S (TTM) at period end3.96×5.25×1.46×1.60×2.19×2.38×3.36×2.96×2.14×6.52×9.12×12.33×7.87×10.26×9.74×–
P/B at period end1.49×1.69×0.50×0.50×0.64×0.58×0.69×0.59×0.75×2.50×1.89×1.88×1.54×1.83×1.83×–
EV / EBITDA (TTM)13.59×15.53×9.01×9.81×10.65×14.19×14.59×7.79×5.19×11.79×14.79×17.45×9.70×12.62×12.15×–
EV / Sales (TTM)7.72×8.79×4.89×5.08×5.75×6.63×8.73×4.68×3.07×7.13×9.40×12.51×7.85×10.28×9.89×–
Returns
Return on equity0.9%2.9%4.8%7.5%7.7%6.1%0.7%17.8%7.8%11.3%(6.0%)8.6%9.0%7.7%5.7%3.9%
Return on invested capital2.9%2.6%3.1%2.6%2.6%1.6%2.4%3.9%8.0%6.4%7.4%6.5%11.9%11.1%11.1%4.2%
Dividend yield7.6%5.6%20.7%19.6%15.7%20.1%17.3%19.7%17.5%7.1%5.9%5.0%5.8%4.5%4.8%–
Financial health
Current ratio–––––––––––––––7.95×
Debt / equity1.46×–––1.13×––0.92×––1.23×0.92×0.82×0.82×0.90×0.58×
Effective tax rate3.3%1.6%(3.1%)(0.9%)(2.5%)(4.3%)(3.1%)(0.5%)(0.3%)39.4%(7.2%)(0.2%)0.7%(0.2%)0.3%0.1%
Share count
Diluted shares outstanding696676547539539531489475469467463459456428400307
StatisticsIncome statementBalance sheetCash flowDividendsSegments

Income statement · USD millions

Line itemTTMFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013FY2012FY2011FY2010
Revenue and gross profit
Revenue$2,950$2,823$2,700$2,181$2,061$1,896$1,645$1,240$1,191$1,848$2,129$1,940$1,637$2,100$1,880$1,694$1,240
Cost of revenue–($2,188)($1,075)($902)($863)($773)($783)($405)($379)($666)($738)($611)($381)($298)($281)($219)–
Gross profit–$635$1,626$1,279$1,198$1,123$862$835$813$1,182$1,391$1,218$1,182$1,715$1,575$1,376–
Operating expenses
Research and development–––––––––––––––––
Selling, general and administrative($91)($90)($97)($95)($131)($98)($93)($93)($97)($89)($104)($96)($82)($103)($68)($96)($83)
Total operating expenses($880)($90)($1,154)($845)($842)($783)($647)($528)($501)($623)($672)($489)($463)($440)($398)($342)–
Total costs and expenses($2,430)($2,278)($2,229)($1,747)($1,705)($1,556)($1,430)($933)($880)($1,290)($1,410)($1,212)($918)($825)($703)($661)($748)
Operating income$519$544$471$434$357$340$215$307$311$559$719$729$719$1,275$1,177$1,034$492
Earnings
EBITDA$1,617$1,603$1,528$1,184$1,067$1,025$769$742$716$1,093$1,287$1,234$1,174$1,699$1,531$1,380$799
Interest income$66$62$45$22$23$38$17$10$10$56$89$112$74$86$25$100$160
Interest expense($337)($305)($280)($200)($173)($158)($218)($218)($261)($308)($464)($480)($440)($435)($416)($415)($286)
Pre-tax income$445$284$273$315$507$128$218$176$839$410$11$136$274$852$745$491$383
Income tax expense($4)($9)($4)$10$4$3$9$5$4$1($4)$10$1($6)$2($1)($0)
Net income$243$71$243$306$500$506$414$46$1,061$414$628($559)$922$971$833$539$331
Per share
Diluted EPS (GAAP)$0.35$0.10$0.36$0.56$0.92$0.93$0.77$0.09$2.24$0.88$1.34($1.21)$2.00$2.13$1.90$1.29$1.00
Basic EPS (GAAP)$0.35$0.10$0.36$0.56$0.92$0.93$0.77$0.09$2.25$0.88$1.34($1.21)$2.01$2.13$1.90$1.29$1.01
Basic shares outstanding694696676547539539531486471469467463458455427398306
Margins
Gross margin–22.5%60.2%58.6%58.1%59.2%52.4%67.3%68.2%64.0%65.3%62.7%72.2%81.7%83.8%81.2%–
Operating margin17.6%19.3%17.4%19.9%17.3%17.9%13.1%24.7%26.1%30.2%33.8%37.6%43.9%60.7%62.6%61.0%39.7%
Net margin8.2%2.5%9.0%14.0%24.3%26.7%25.1%3.7%89.1%22.4%29.5%(28.8%)56.3%46.2%44.3%31.8%26.7%